BI Asset Management Fondsmaeglerselskab’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.91M Buy
46,033
+38,025
+475% +$4.6M 0.04% 287
2026
Q1
$1.31M Sell
8,008
-22,519
-74% -$3.46M 0.01% 450
2025
Q4
$5.31M Sell
30,527
-6,897
-18% -$1.26M 0.05% 252
2025
Q3
$5.39M Sell
37,424
-47,678
-56% -$5.84M 0.05% 255
2025
Q2
$8.56M Buy
85,102
+83,644
+5,737% +$6.4M 0.08% 186
2025
Q1
$111K Sell
1,458
-29,932
-95% -$2.29M ﹤0.01% 674
2024
Q4
$2.17M Buy
+31,390
New +$2.26M 0.02% 337

Other funds holding INSM

BI Asset Management Fondsmaeglerselskab's INSM Position: Q2 2026 in Review

BI Asset Management Fondsmaeglerselskab increased its Insmed (INSM) stake by 475% in Q2 2026, buying an estimated $4.6M and bringing the position to 46,033 shares worth $4.91M. The position accounts for 0.04% of the portfolio, ranked #287.

BI Asset Management Fondsmaeglerselskab first reported a position in INSM in Q4 2024 and has held it in 7 quarters since. The position peaked at $8.56M in Q2 2025. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • BI Asset Management Fondsmaeglerselskab held 46,033 shares of Insmed worth $4.91M as of Q2 2026.
  • BI Asset Management Fondsmaeglerselskab bought 38,025 Insmed shares in Q2 2026, an estimated $4.6M.
  • Insmed made up 0.04% of BI Asset Management Fondsmaeglerselskab's portfolio in Q2 2026, its #287 holding.
  • BI Asset Management Fondsmaeglerselskab first reported a position in Insmed in Q4 2024 and has held it in 7 quarters since.
  • BI Asset Management Fondsmaeglerselskab's Insmed position peaked at $8.56M in Q2 2025.
  • 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q2 2026, filed 10 Aug 2026.